Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Wilms' tumor protein, commonly referred to as WT1, is a transcription factor encoded by the WT1 gene. It plays a critical role in the development of the urogenital system and is essential for normal kidney formation. Mutations or deletions in this gene are associated with Wilms' tumor and other developmental syndromes. WT1 acts as a transcription factor regulating genes involved in cell differentiation, epithelial/mesenchymal transition control, cell proliferation, and apoptosis. It has both tumor suppressor and oncogenic roles depending on the cellular context.
Currently, there are no drugs directly targeting WT1. Research focuses on inhibiting WT1 expression or function indirectly through other pathways.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Wilms' Tumor Protein 1 (WT1).